← Back to latest intelligence

Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness

Editorial abstract

The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.

This is not the publisher’s original article. Unreviewed abstracts are mechanically condensed from source-provided material; editor-reviewed abstracts have completed editorial review.

Story classification

Topics

War, Deterrence, and Regional Escalation · High confidence · AutomaticStory-text match

Regions

Global · Low confidence · AutomaticBroad source default; editorial correction recommended

Read original at BBC News - World ↗